Which of the below ultra-rapid-acting insulins has an ~12-minute "onset of action" and 30-54-minute "peak action?"

Sep 25, 2025

Which course of treatment did Dr Wysham recommend for her 60 y/o male patient with A1c at 5.6%, LDL at 88, family history of T2D/cirrhosis, and MASH/high risk for fibrosis confirmed by a liver specialist?

Sep 4, 2025

Which course of treatment did Dr Isaacs recommend for her male 68 years-old T2D patient on statins and acarbose who presented with A1C+6.5%, FIB-4=1.4, and Fibroscan, LSM of 9.9kPa?

Aug 22, 2025

Which is true?

Aug 1, 2025

Which of the below is true?

May 30, 2025

An article published in the American Journal of Medicine in 2020 examines which of the following about Type 2 Diabetes?

May 9, 2025

An article by AASLD published in Hepatology in 2024 on MASLD practice guidance recommends a multidisciplinary approach consisting of:

Apr 24, 2025

According to AACE Guidelines published in EndocrinePractice.org in 2022 on MASLD management:

Apr 4, 2025

Per Dr Plante's presentation, the reason(s) we need faster insulins is/are:

Aug 1, 2024

According to Dr Forlenza's presentation, while most people using Control I-Q technology bolus every day, nearly 1 in 10 have gone 7+ days without bolusing with no increased hypoglycemia.

Jul 18, 2024

Which is true about the t:slim X2 insulin pump?

May 31, 2024

What have been some specific changes for Corine (PwD) while using a smart insulin pen?

Apr 4, 2024

As discussed by Dr Ahn and Melissa (PwD), what is her issue of most concern?

Mar 28, 2024

Which of the below conditions have specifically improved for PwD Jasmin, using the Smart Insulin Pen in partnership with Dr Jones?

Mar 15, 2024

Some of the benefits of smart insulin pens (SIPs) for people on MDI are that they can:

Dec 1, 2023

Some of the benefits smart insulin pens (SIPs) provide to people on MDI are:

Nov 3, 2023

Which below medication is currently in Phase 3 clinical development for the treatment of NASH?

Sep 1, 2023

According to DiabetesWise Pro (pro.diabeteswise.org), one/some of the best ways to introduce a diabetes technology device to a patient is/are:

Aug 24, 2023

A/some of the unique thing(s) about Omnipod 5 insulin pump is/are:

Jan 12, 2023

Per Dr Isaacs' presentation, statistics show that most people with type 2 diabetes have hepatic steatosis.

Dec 7, 2022

A study to evaluate the safety and effectiveness of the Omnipod 5 System over 12 months of use in children with T1D aged 2 to <6 demonstrated 49% achieved HbA1c of <7.0% compared with 31% at baseline.

Aug 16, 2022

The implantable sensor of the newly FDA approved 180-days CGM system measures in length as the diameter of which of the following US coins?

May 25, 2022

The PROMISE study, published in Diabetes Technology & Therapeutics in February 2022, was completed in order to evaluate:

Mar 25, 2022

AID systems provide benefit and may reduce patient's self care burden

Jan 6, 2022

As discussed by Dr Forlenza in his presentation, \"Novel AID Systems on the Horizon,\" some forthcoming innovative features are

Dec 22, 2021

As presented by Dr Buckingham, recent clinical trials of a novel automated insulin delivery (AID) system vs. standard therapy (ST) in both adults and children show:

Nov 19, 2021

Recent studies of a novel AID system for pediatric and young adults population demonstrated:

Oct 22, 2021

From AACE Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus, published 2021

Sep 17, 2021

A recent pivotal study of a novel AID system, revealed:

Aug 25, 2021

What are device factors to consider when helping your patient select an AID system?

Aug 20, 2021

Per Dr Hirsch, core components of Smart Insulin Pens include:

Aug 19, 2021

Per Dr Hirsch, smart insulin pens allow patients and providers to see granularity of insulin dosing such as "missed/late doses and calculated dosing to avoid stacking":

Aug 5, 2021

Which is correct?

Jul 30, 2021

Time-in-range outcomes from a recent clinical study of a novel tubeless AID system revealed:

Jul 22, 2021

The use of a bolus calculator feature in novel smart insulin pens benefits people with diabetes by:

Jul 15, 2021

Cutting-edge features of a novel Smart Insulin Pen with Advanced Decision support could include which of the following innovations:

Jun 18, 2021

Clinical trial of the Omnipod 5 system confirms:

Jun 17, 2021

What clinical improvements should be expected from novel AID systems?

Jun 10, 2021

Smart Insulin Pen users benefit from individualized digital tools similar to those found in insulin pumps, but with lower cost and the freedom of not being continuously tethered to a pump.

Jun 3, 2021

Cohort studies and managed care data analysis of insulin pen usage compared with vial and syringe users, confirm which of the following:

May 25, 2021

As discussed during Diabetes Technology Roundtable V, recent studies evaluating safety and effectiveness of a tubeless AID system in patients with type 1 diabetes demonstrated:

May 20, 2021

Clinical trials data and case studies to be presented by Distinguished Faculty on May 6th at the www.cgmEDUCATION.net Diabetes Technology Roundtable V, report which, regarding novel Insulin Pumps and AID systems?

Apr 22, 2021

As presented during the DTR IV, Novel AID systems scheduled to be introduced in the near future will have which of the following innovative features?

Apr 1, 2021

A June 2020 published article by Dr Hirsch et al on real-world insulin delivery, reports:

Dec 18, 2020

As presented during the DTR III, can pump/CGM combinations attain consistent TIR for adults and children?

Nov 19, 2020

As presented during the DTR III, "Pod pumps" are a good fit for older T2s since Medicare will often not approve tubed pumps for this population.

Oct 29, 2020

As presented by Dr Diana Isaacs during the DTR II, Glooko Data Uploads show which of the following statistics with respect to Omnipod and CGM users maintaining time in range (TIR 70-180 m/dl) in the US and Canada?

Oct 9, 2020

According to Diana Isaacs, PharmD in the Diabetes Technology Roundtable II, and the ADA Standards of Care in Diabetes 2020 guidelines, who can benefit from insulin pump therapy?

Oct 2, 2020

According to Dr Gregory Forlenza in the Diabetes Technology Roundtable II, some advantages of using an insulin pump are:

Sep 25, 2020

Per a recently published article, onboarding and in-the-moment management via telehealth of a new-onset type 1 diabetes pediatric patient at Barbara Davis Center in Colorado, successfully used which combination of diabetes devices?

Aug 6, 2020

A recent article on telemedicine by Drs Garg, Rodbard, Hirsch and Forlenza, concludes which of the following?

Jul 29, 2020

While insulin pumps have been used in the United States for more than 30 years, recent statistics estimated which of the following regarding the percentage of patients with Type 2 diabetes utilizing pumps?

Jun 23, 2020

Findings from a 3-month, multicenter, retrospective study on Type 2 Diabetes treatment with a tubeless insulin pump, showed:

Jun 17, 2020

Which of the following is true regarding Type 2 Diabetes (T2D) treatment with insulin pumps?

Jun 12, 2020

Which of the following is true according to the article, Do We Need Updated Guidelines on the Use of Insulin Pump Therapy in Type 2 Diabetes?

Jun 3, 2020

Smart insulin pens may have which of the following features:

Apr 24, 2020

Which of the following is/are correct as discussed in the article by TS Bailey et al, A novel pen-based Bluetooth-enabled insulin delivery system with insulin dose tracking and advice:

Apr 10, 2020

Which of the following feature(s) is/are part of integrated smart insulin pen systems?

Mar 11, 2020

According to an article in Medical News Today an observational study from 2015 showed that diabetes patients using insulin pens are:

Feb 27, 2020

In 2019, the FDA approved the first Bluetooth enabled insulin pen:

Feb 21, 2020

The first insulin pen was introduced in...

Feb 14, 2020

The first known mention of diabetes symptoms, frequent urination as a symptom of a mysterious disease that also caused emaciation, was documented in...

Feb 7, 2020

What causes insulin resistance and prediabetes, according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)?

Jan 31, 2020

The HypoDE randomized control trial demonstrated that:

Jan 24, 2020

According to the American Diabetes Association, 84 million American adults have prediabetes; how many of them don't know they have it?

Jan 17, 2020

The Center for Disease Control (CDC)^* released a report on 12.30.19 stating which of the following:

Dec 30, 2019

According to a 2005-2016 study of 5,786 US adolescents (aged 12 to 18) and young adults (aged 19 to 34), recently published in JAMA Pediatrics¹, which of the following is the emerging health threat that can lead to type 2 diabetes:

Dec 19, 2019

In 1916, Boston scientist Elliott Joslin established himself as one of the world's leading diabetes experts by creating the textbook The Treatment of Diabetes Mellitus, which reported which of the following:

Nov 21, 2019

Please select the correct statement below.

Oct 25, 2019

The I HART CGM study concluded that:

Mar 15, 2019

Who can bill for current procedural terminology (CPT) CGM code 95251?

Feb 14, 2019

Which one of the following statement(s) is(are) correct of CGM use according to findings from the DIaMonD and GOLD studies:

Jan 31, 2019

What are some requirements for CGM as durable medical equipment (DME) to be eligible for Medicare coverage?

Nov 16, 2018

With the use of CGM, clinicians are now able to treat their patients differently by:

Nov 9, 2018

Which of the following is an important consideration when giving a post-meal insulin bolus with the aid of CGM based trend arrows dosing in order to avoid hypoglycemia in persons using multiple daily insulin therapy?

Oct 11, 2018

What are ideal criteria to use continuous glucose monitoring (CGM)?

Sep 13, 2018

Real-time continuous glucose monitoring (rtCGM) facilitates our understanding of the relationship between:

Aug 15, 2018

Which of the following is true regarding the clinical evidence supporting real-time continuous glucose monitoring (rtCGM) as a standard of care?

Jul 19, 2018

The DIaMonD (Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes) trial found that:

May 24, 2018

The GOLD trial was notable for providing evidence that:

May 3, 2018

While wearing CGM, patients should consider:

Mar 20, 2018

The DIaMonD (Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes) Trial found that...

Jan 19, 2018

The DIaMonD (Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes) Trial found that...

Oct 26, 2017

The DIaMonD (Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes) Trial found that...

Sep 21, 2017

The best candidates for CGM may include...

Mar 14, 2017

Previous studies involving patients with T1D have shown that...

Jan 9, 2017

With CGM, what is the role of the pharmacist?

Jan 5, 2017

What is most important when evaluating CGM?

Dec 6, 2016

In your experience, what have most studies about CGM demonstrated?

Nov 18, 2016

What percentage of your patients would benefit from Real-Time CGM?

Jun 12, 2014